Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) — Form 10-Q: Quarterly report
About this filing
Iovance Biotherapeutics, Inc. (IOVA) filed Form 10-Q (quarterly report) with the SEC on Nov 5, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More IOVA filings
- 4
Filed Nov 10, 2026
- SC 13G
Filed Nov 10, 2026
- 8-K
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.